Date
4-2024
Project Type
URC Presentation
College or School
PAUL
Class Year
Senior
Major
Finance
Faculty Research Advisor
Steven Irlbeck
Abstract
The impact of the Inflation Reduction Act of 2022 on the financial strategies of pharmaceutical companies is the focus of this study, emphasizing research and development (R&D) and capital expenditures. The act introduces a paradigm shift in U.S. healthcare policy by enabling Medicare to directly negotiate the prices of select drugs. Employing a difference-in-differences analysis framework, this study analyzes data from both treated and control firms from Q1 2020 to Q4 2023 to evaluate the immediate financial responses of pharmaceutical companies to this significant legislative change.
Recommended Citation
Harbour, Grace, "The Inflation Reduction Act’s Role in Shaping Pharmaceutical Investment Strategies" (2024). Undergraduate Research Conference (URC) Student Presentations. 584.
https://scholars.unh.edu/urc/584